跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,010 条关于
“Yuanta Securities”
全部
1,010
临床试验
84
药物
37
机构
58
资讯
831
18天前
Bio Visu's U.S. Sales Surge Past 7 Billion Won as ECM Skin Booster Business Fuels Global Expansion
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
9个月前
Galux Secures $29 Million Series B to Advance AI-Driven Protein Design Platform
去年
Serina Therapeutics and enVVeno Medical Each File $100M Mixed Securities Shelf
去年
Iovance CFO Resigns Amid Amtagvi Launch Struggles and Securities Fraud Investigation
去年
Alnylam's Amvuttra Poised to Become First-Line ATTR-CM Treatment
去年
Agios Pharmaceuticals Faces Securities Fraud Investigation Following FDA Delay of PYRUKYND Approval
去年
Click Therapeutics Highlights PDURS Potential to Revolutionize Digital Therapeutics
去年
Cassava Sciences Faces Class Action Lawsuit After Simufilam Fails Phase 3 Trial
去年
NLS Pharmaceutics and NewAmsterdam Pharma File Mixed Securities Shelves Worth $75M and $500M Respectively
第 1 页,共 84 页
上一页
下一页